# Task V03: Product Development Plans

> **NIH NIH N01** · INTERNATIONAL AIDS VACCINE INITIATIVE · 2021 · $666,400

## Abstract

The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of services spanning product development planning and feasibility assessments; product optimization; product development and cGMP compliant manufacture for Phase I/II clinical studies; technical and facility audits; and regulatory support appropriate for submission to the U.S. Food and Drug Administration (FDA).  These services will facilitate the development and introduction of new vaccines and biologics against a wide array of infectious diseases.  This contract also provides for manufacture of candidate vaccines, vaccine components including adjuvants, vaccine delivery systems, other biologics, and challenge material.

## Key facts

- **NIH application ID:** 10390262
- **Project number:** 272201800010I-P00002-759301900131-1
- **Recipient organization:** INTERNATIONAL AIDS VACCINE INITIATIVE
- **Principal Investigator:** THOMAS HASSELL
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $666,400
- **Award type:** —
- **Project period:** 2018-05-15 → 2028-05-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10390262

## Citation

> US National Institutes of Health, RePORTER application 10390262, Task V03: Product Development Plans (272201800010I-P00002-759301900131-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10390262. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*